ABEO – Abeona Therapeutics Inc
ABEO — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
29.63
Margin Of Safety %
Put/Call OI Ratio
0.27
EPS Next Q Diff
0.05
EPS Last/This Y
-2.25
EPS This/Next Y
1.15
Price
4.82
Target Price
19.57
Analyst Recom
1
Performance Q
-7.85
Upside
627.7%
Beta
1.25
Ticker: ABEO
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | ABEO | 5.16 | 0.20 | 0.48 | 44127 |
| 2026-03-10 | ABEO | 5.14 | 0.20 | 0.43 | 44913 |
| 2026-03-11 | ABEO | 5.01 | 0.24 | 0.14 | 50272 |
| 2026-03-12 | ABEO | 4.96 | 0.25 | 0.16 | 50962 |
| 2026-03-13 | ABEO | 4.95 | 0.25 | 0.16 | 50962 |
| 2026-03-17 | ABEO | 4.77 | 0.25 | 0.18 | 52794 |
| 2026-03-18 | ABEO | 4.56 | 0.24 | 0.10 | 53944 |
| 2026-03-20 | ABEO | 4.47 | 0.22 | 0.18 | 57333 |
| 2026-03-25 | ABEO | 4.42 | 0.22 | 0.97 | 23723 |
| 2026-03-26 | ABEO | 4.34 | 0.23 | 0.46 | 23997 |
| 2026-03-27 | ABEO | 4.29 | 0.23 | 1.17 | 24552 |
| 2026-03-30 | ABEO | 4.24 | 0.23 | 2.70 | 24753 |
| 2026-03-31 | ABEO | 4.49 | 0.24 | 0.66 | 25070 |
| 2026-04-01 | ABEO | 4.59 | 0.24 | 1.37 | 25525 |
| 2026-04-06 | ABEO | 4.77 | 0.26 | 4.23 | 26074 |
| 2026-04-07 | ABEO | 4.82 | 0.27 | 6.11 | 26397 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | ABEO | 5.16 | -7.6 | - | -0.14 |
| 2026-03-10 | ABEO | 5.13 | -7.6 | - | -0.14 |
| 2026-03-11 | ABEO | 5.01 | -7.6 | - | -0.14 |
| 2026-03-12 | ABEO | 4.96 | -7.6 | - | -0.14 |
| 2026-03-13 | ABEO | 4.77 | -18.2 | - | -0.14 |
| 2026-03-17 | ABEO | 4.76 | -18.2 | - | -0.14 |
| 2026-03-18 | ABEO | 4.55 | -18.2 | - | -0.14 |
| 2026-03-19 | ABEO | 4.56 | -18.2 | - | -0.14 |
| 2026-03-20 | ABEO | 4.47 | -63.9 | - | -0.91 |
| 2026-03-23 | ABEO | 4.43 | -63.9 | - | -0.91 |
| 2026-03-24 | ABEO | 4.34 | -63.9 | - | -0.91 |
| 2026-03-25 | ABEO | 4.42 | -63.9 | - | -0.91 |
| 2026-03-26 | ABEO | 4.33 | -63.9 | - | -0.91 |
| 2026-03-27 | ABEO | 4.30 | -63.9 | - | -0.91 |
| 2026-03-30 | ABEO | 4.24 | -63.9 | - | -0.91 |
| 2026-03-31 | ABEO | 4.49 | -63.9 | - | -0.91 |
| 2026-04-01 | ABEO | 4.58 | -63.9 | - | -0.91 |
| 2026-04-02 | ABEO | 4.83 | -63.9 | - | -0.91 |
| 2026-04-06 | ABEO | 4.78 | -63.9 | - | -0.91 |
| 2026-04-07 | ABEO | 4.82 | -63.9 | - | -0.91 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | ABEO | -4.98 | 6.52 | 28.27 |
| 2026-03-10 | ABEO | -4.98 | 6.52 | 28.27 |
| 2026-03-11 | ABEO | -4.98 | 6.52 | 26.96 |
| 2026-03-12 | ABEO | -4.98 | 6.52 | 26.96 |
| 2026-03-13 | ABEO | -4.98 | 6.52 | 26.96 |
| 2026-03-18 | ABEO | -4.99 | 6.62 | 26.96 |
| 2026-03-19 | ABEO | -4.99 | 6.62 | 26.96 |
| 2026-03-20 | ABEO | -4.75 | 6.62 | 25.61 |
| 2026-03-23 | ABEO | -4.74 | 6.26 | 25.61 |
| 2026-03-24 | ABEO | -4.74 | 6.26 | 25.61 |
| 2026-03-25 | ABEO | -4.74 | 6.26 | 29.63 |
| 2026-03-26 | ABEO | -4.74 | 6.26 | 29.63 |
| 2026-03-27 | ABEO | -4.74 | 6.26 | 29.63 |
| 2026-03-30 | ABEO | -4.74 | 6.26 | 29.63 |
| 2026-03-31 | ABEO | -4.74 | 6.26 | 29.63 |
| 2026-04-01 | ABEO | -5.18 | 6.26 | 29.63 |
| 2026-04-02 | ABEO | -4.25 | 6.26 | 29.63 |
| 2026-04-06 | ABEO | -4.25 | 6.74 | 29.63 |
| 2026-04-07 | ABEO | -4.25 | 6.74 | 29.63 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.34
Avg. EPS Est. Current Quarter
-0.39
Avg. EPS Est. Next Quarter
-0.29
Insider Transactions
-4.25
Institutional Transactions
6.74
Beta
1.25
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
14
Fair Value
Quality Score
99
Growth Score
34
Sentiment Score
80
Actual DrawDown %
90.6
Max Drawdown 5-Year %
-95.6
Target Price
19.57
P/E
4.82
Forward P/E
35.63
PEG
8.82
P/S
47.15
P/B
1.66
P/Free Cash Flow
EPS
1
Average EPS Est. Cur. Y
-0.91
EPS Next Y. (Est.)
0.24
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
1223.08
Relative Volume
0.8
Return on Equity vs Sector %
17.2
Return on Equity vs Industry %
33.8
EPS 1 7Days Diff
-0.5
EPS 1 30Days Diff
-0.84
EBIT Estimation
◆
ABEO
Healthcare
$4.81
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
53.6
Range 1M
56%
Sup Dist
2.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-173.1%
EPS NY
118.3%
52W%
25.2%
Long-Term Value
Quality companies, undervalued
WATCH
🟢 BUY
+141% upside
Upside
+141%
Quality
99
Abeona Therapeutics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 226
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
ABEO
Latest News
—
Caricamento notizie per ABEO…
stock quote shares ABEO – Abeona Therapeutics Inc Stock Price stock today
news today ABEO – Abeona Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ABEO – Abeona Therapeutics Inc yahoo finance google finance
stock history ABEO – Abeona Therapeutics Inc invest stock market
stock prices ABEO premarket after hours
ticker ABEO fair value insiders trading